Sandoz launches Hyrimoz® (adalimumab) high-concentration formulation in Europe, aiming to improve patient care 21-11-2023, 13:00

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer 8-10-2025, 18:09

Probiotics Market Size to Hit USD 94.48 Billion by 2027 | 8-03-2023, 18:42